High Dose PPI denied as not medically necessary by Cigna?

Cigna's specific coverage criteria for high dose ppi are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denies High-Dose PPI as Not Medically Necessary

Cigna's medical-necessity denials for high-dose PPI therapy most commonly occur when the clinical documentation submitted with the prior authorization or the claim does not clearly establish (a) a diagnosis that Cigna's policy recognizes as warranting high-dose acid suppression, or (b) that standard-dose therapy has been tried and found inadequate. Because high-dose PPI represents an escalation beyond first-line treatment, Cigna expects documentation of both the clinical indication and the failure of less intensive treatment.

## Why This Denial Is Appealable

High-dose PPI therapy is guideline-supported by the American College of Gastroenterology and the American Gastroenterological Association for specific indications including severe erosive disease, Barrett's esophagus, and hypersecretory states. If the prescribing clinician has documented a qualifying diagnosis and a clinical basis for escalation, the denial rests on incomplete documentation rather than a genuine absence of medical necessity — and is directly reversible on appeal with the right evidence.

## Your Federal Appeal Rights

• Internal appeal: Under ERISA §503 (employer-sponsored plans) or applicable state insurance law, you are entitled to a full-and-fair internal review. File within the timeframe on the denial letter, typically 180 days for ERISA plans.
• External review: After exhausting the internal appeal, ACA §2719 provides the right to independent external review by an accredited IRO. The standard window is approximately four months from the final internal adverse determination. Expedited external review is available if the patient is experiencing severe ongoing symptoms or if a time-sensitive clinical decision (e.g., surgery) depends on the outcome.

## Concrete Appeal Steps and Timeline

1. Obtain the full denial letter and Cigna's applicable Clinical Policy Bulletin for PPI therapy. 2. Map every stated deficiency in the denial to the clinical record — determine what documentation is missing or was not submitted. 3. Have the treating gastroenterologist or internist draft a targeted letter of medical necessity addressing each stated deficiency. 4. Submit a Level 1 internal appeal within the deadline. 5. If denied, file for external IRO review within the window on the denial notice.

## Documentation to Gather

• Diagnosis confirmation: Endoscopy with pathology report, ambulatory pH or impedance-pH study, or other objective testing confirming the diagnosis (erosive esophagitis grade, Barrett's, hypersecretory state, etc.).
• Step-therapy / treatment failure history: A chronological list of prior acid-suppression therapy — drug names, doses, treatment duration, and documented inadequacy of response — with chart notes or symptom diaries as supporting evidence.
• Clinical severity: Physician notes quantifying the impact on the patient (weight loss, dysphagia, nocturnal symptoms, aspiration events, or stricture) that demonstrate why standard dosing is insufficient.
• Prescriber letter of medical necessity: A diagnosis-specific letter from the treating clinician explaining the escalation rationale, referencing the applicable ACG or AGA guideline organization recommendation, and documenting how the patient's chart satisfies each of Cigna's published criteria.
• Current medication list: Confirms that no current regimen is already providing adequate acid suppression.

## Criteria-Mapping Structure

Recreate Cigna's medical-necessity criteria from the Clinical Policy Bulletin as a checklist. For each criterion, cite the specific chart document, date, and finding that satisfies it. For any criterion not yet met in the record, discuss with the treating clinician whether it can be met through additional objective testing before the appeal is filed — adding that evidence before submission is far more effective than arguing against the criterion on appeal.